The Next Generation Antibody Therapeutics Market will witness a CAGR of 13% by reaching US$ 6.76 Billion from 2022. The new-fangled healthcare electronic technologies like 3D printing, GPS tracking, and wearable biometric devices are being tested concerning clinical use. Cutting-edge technology is expected to be one of the driving forces in the healthcare industry in the subsequent decade.
According to a new market report published by Persistence Market Research “Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022”, the global next-generation antibody therapeutics market is project to be valued at US$ 2,250.0 Mn by the end of 2015 and is expected to expand at a CAGR of 13.0% from 2015 to 2022, to account for US$ 6,761.1 Mn by 2022.
Next-generation antibody therapeutics refers to improved antibody therapeutics with enhanced efficiency, greater safety, and improved delivery. Advancements in monoclonal antibody technologies have led to the development of next-generation therapeutic antibodies with reduced functional size, greater bifunctional properties, and low immunogenicity.
Planning Forward? Access Sample Of Next Generation Antibody Therapeutics Market Report! https://www.persistencemarketresearch.com/samples/3713
Some of the major players in the market:
- Hoffmann-La Roche Ltd.
- Kyowa Hakko Kirin Co., Ltd.
- Seattle Genetics, Inc.
- ImmunoGen, Inc.
- Amgen, Inc.
- Bayer AG.
- Xencor, Inc.
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Next Generation Antibody Therapeutics Market? https://www.persistencemarketresearch.com/methodology/3713
Next-generation antibody-based therapeutics enhances existing properties of therapeutic antibodies for the treatment of various medical conditions such as cancer, infectious diseases, and autoimmune diseases.
Globally, the next-generation antibody therapeutics market is witnessing significant growth due to technological advancements in antibody therapeutics and increasing the prevalence of chronic diseases. In addition, rising healthcare expenditure and growing R & D activities are driving the growth of the next-generation antibody therapeutics market.
However, stringent regulatory requirements and long approval time for new drug restrains the growth of the market. Similarly, high costs of next-generation antibody therapeutics is a major concern for the market.
Planning To Introduce An Offbeat Product/Technology In The Next Generation Antibody Therapeutics Market? Go To “Purchase Now” To Have Our Next Generation Antibody Therapeutics Market Report! https://www.persistencemarketresearch.com/checkout/3713
North America is the largest market for next-generation antibody therapeutics. This is mainly due to increasing prevalence of chronic diseases and increasing healthcare spending in the region. The North America next-generation antibody therapeutics market is projected to be valued at US$ 1,104.4 Mn by the end of 2015 and is expected to account for US$ 3,691.8 Mn by 2022 at a CAGR of 14.5%.
On the basis of technology, biosimilar antibody products are the fastest growing segment. On the basis of therapeutic application, oncology is the largest segment in next-generation antibody therapeutics market.
Access Related Reports:
E-Clinical Solution Software Market:
According to a new market report published by Persistence Market Research “Global Market Study on E-Clinical Solution Software: Asia to Witness Highest Growth by 2020”, the global e-clinical solution software market was valued at US$ 3,005 Mn in 2014 and is expected to expand at a CAGR of 13.8% from 2014 to 2020, to reach US$ 6,515.3 Mn by 2020.
Biosimulation Market:
The global biosimulation market is slated to touch a value of about US$ 1,750 Mn in the year 2022 and grow at a robust CAGR during the assessment period.
Digital Intraoral Sensors and Consumables Market:
Persistence Market Research (PMR) delivers the key insights on the global digital intraoral sensors and consumables market in its upcoming report titled “Digital Intraoral Sensors and Consumables Market: Global Industry Analysis 2013–2017 and Forecast 2018–2026”. In terms of revenue, the global digital intraoral sensors and consumables market is expected to grow at a promising CAGR of 5.0% over the next decade.
Non-Invasive Ventilation Masks and Circuits:
Adoption of non-invasive ventilation masks and circuits will increase due to large procedural benefits that they offer – masks provide an optimal fit, along with minimizing pressure and leakage points.
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com